These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2735567)

  • 1. [Antifungigram: interpretation and choice of a technic].
    Vermorel O; Lebeau B; Claustre F; Grillot R
    Ann Biol Clin (Paris); 1989; 47(2):85-90. PubMed ID: 2735567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility testing in fungi: a global perspective on a variety of methods.
    Lass-Flörl C; Perkhofer S; Mayr A
    Mycoses; 2010 Jan; 53(1):1-11. PubMed ID: 20078786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
    Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
    Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro assessment of antifungal drug resistance.
    Holmberg K
    Acta Derm Venereol Suppl (Stockh); 1986; 121():131-8. PubMed ID: 3459340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of in vitro antifungal susceptibility testing.
    Espinel-Ingroff A
    Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One.
    Carrillo-Muñoz AJ; Quindós G; Ruesga M; del Valle O; Pemán J; Cantón E; Hernández-Molina JM; Santos P
    Mycoses; 2006 Jul; 49(4):293-7. PubMed ID: 16784443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determining the susceptibility of microfungi to antifungals and interpreting the results].
    Mallátová N
    Klin Mikrobiol Infekc Lek; 2007 Aug; 13(4):150-5. PubMed ID: 17929220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibility testing method for resource constrained laboratories.
    Khan S; Singhal S; Mathur T; Upadhyay DJ; Rattan A
    Indian J Med Microbiol; 2006 Jul; 24(3):171-6. PubMed ID: 16912435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
    Vivas JR; Torres-Rodríguez JM
    Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues in antifungal susceptibility testing.
    Johnson EM
    J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i13-8. PubMed ID: 18063599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effectiveness of 13 agents in otomycosis and review of the literature.
    Stern JC; Shah MK; Lucente FE
    Laryngoscope; 1988 Nov; 98(11):1173-7. PubMed ID: 3054372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility testing methods of antifungal agents.
    Ernst EJ
    Methods Mol Med; 2005; 118():3-12. PubMed ID: 15888930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the results of in vitro antifungal susceptibility testing using the Fungitest kit and the disc diffusion test].
    Buchta V; Navrátilová L; Förstl M; Kubanová P
    Klin Mikrobiol Infekc Lek; 2004 Apr; 10(2):80-7. PubMed ID: 15146386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibility testing: progress and future developments.
    Pfaller MA
    Braz J Infect Dis; 2000 Apr; 4(2):55-60. PubMed ID: 11012296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Mexican isolates of yeasts and moulds to amphotericin B and triazole antifungals.
    Arredondo-García JL; Amábile-Cuevas CF;
    J Infect Dev Ctries; 2009 Jun; 3(5):398-401. PubMed ID: 19759511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans.
    Petrikkou E; Rodríguez-Tudela JL; Cuenca-Estrella M; Gómez A; Molleja A; Mellado E
    J Clin Microbiol; 2001 Apr; 39(4):1345-7. PubMed ID: 11283054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An update on antifungal susceptibility testing].
    Tapia P CV
    Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mycoses].
    Yamazumi T; Furuta I
    Rinsho Byori; 2002 Sep; 50(9):853-9. PubMed ID: 12386962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.